Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
298,234
Value
$186.0M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026298,234$186.0M<0.1%−1,745−0.6%ReducedHolders
Q1 2026299,979$231.8M<0.1%+28,821+10.6%AddedHolders
Q4 2025271,158$209.3M<0.1%−68,331−20.1%ReducedHolders
Q3 2025339,489$190.9M<0.1%+45,974+15.7%AddedHolders
Q2 2025293,515$154.1M<0.1%+6,352+2.2%AddedHolders
Q1 2025287,163$182.1M<0.1%−95,672−25.0%ReducedHolders
Q4 2024382,835$272.7M0.1%+110,985+40.8%AddedHolders
Q3 2024271,850$285.8M0.1%+17,389+6.8%AddedHolders
Q2 2024254,461$267.4M0.1%−3,020−1.2%ReducedHolders
Q1 2024257,481$247.8M0.1%+122,544+90.8%AddedHolders
Q4 2023134,937$118.5M<0.1%+30,517+29.2%AddedHolders
Q3 2023104,420$85.9M<0.1%−56,022−34.9%ReducedHolders
Q2 2023160,442$115.3M0.1%+58,598+57.5%AddedHolders
Q1 2023101,844$83.7M<0.1%−37,451−26.9%ReducedHolders
Q4 2022139,295$100.5M<0.1%+88,154+172.4%AddedHolders
Q3 202251,141$35.2M<0.1%−73,182−58.9%ReducedHolders
Q2 2022124,323$73.5M<0.1%+18,975+18.0%AddedHolders
Q1 2022105,348$73.6M<0.1%−83,823−44.3%ReducedHolders
Q4 2021189,171$119.5M<0.1%−16,706−8.1%ReducedHolders
Q3 2021205,877$124.6M0.1%+48,150+30.5%AddedHolders
Q2 2021157,727$88.1M<0.1%−760−0.5%ReducedHolders
Q1 2021158,487$75.0M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.